Search
for
Sort by
Research 541–570 of 1000+
- Hair disorders associated with post-COVID-19 infection in females: a cross-sectional study
- Evaluation of patients with telogen effluvium during the pandemic: May the monocytes be responsible for post COVID‐19 telogen effluvium?
- Prominent Cutaneous Manifestation of COVID-19: A Case Report
- Azithromycin with nitazoxanide, hydroxychloroquine or ivermectin, with or without dutasteride, for early stage COVID-19: an open-label prospective observational study in males with mild-to-moderate COVID-19 (The Pre-AndroCoV Male Trial).
- Azithromycin with nitazoxanide, hydroxychloroquine or ivermectin, with or without dutasteride, for early stage COVID-19: an open-label prospective observational study in males with mild-to-moderate COVID-19 (The Pre-AndroCoV Male Trial).
- Prevalence of Hair Loss After COVID-19 Infection in Makkah Region, Saudi Arabia
- Estimating long COVID-19 prevalence across definitions and forms of sample selection
- The COVID-19 Sequelae: A Cross-Sectional Evaluation of Post-recovery Symptoms and the Need for Rehabilitation of COVID-19 Survivors
- Post-Acute COVID-19 Sequelae – ‘COVID Long Hauler’
- Long-COVID Clinical Features and Risk Factors: A Retrospective Analysis of Patients from the STOP-COVID Registry of the PoLoCOV Study
- Proxalutamide (GT0918) Reduces the Rate of Hospitalization in mild-to-moderate COVID-19 Female Patients: A Randomized Double-Blinded Placebo-Controlled Two-Arm Parallel Trial
- Risk factors and early preventive measures for long COVID in non-hospitalized patients: analysis of a large cohort in the United Arab Emirates
- Blood group O and post-COVID-19 syndrome
- Safety and efficacy of the COVID-19 vaccine in children and/or adolescents:A meta-analysis
- Female Sex Is a Risk Factor Associated with Long-Term Post-COVID Related-Symptoms but Not with COVID-19 Symptoms: The LONG-COVID-EXP-CM Multicenter Study
- Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areata
- Rash morphology as a predictor of COVID‐19 severity: A systematic review of the cutaneous manifestations of COVID‐19
- Enzyme Inhibitors from Gorgonians and Soft Corals
- Pemanfaatan Bubuk Bawang Merah Brebes untuk Meningkatkan Durabilitas Mi Basah
- Understanding the Intricate Pathophysiology of Psoriasis and Related Skin Disorders
- Efficacy and safety of proxalutamide (GT0918) in severe or critically ill patients with COVID-19: study protocol for a prospective, open-label, single-arm, single-center exploratory trial
- Prevalence of hair loss in Egyptian people after covid -19 vaccination.
- CARACTERÍSTICAS CLÍNICAS DO EFLÚVIO TELÓGENO INDUZIDO PELA INFECÇÃO DE COVID-19: REVISÃO INTEGRATIVA
- Human adipose tissue–derived mesenchymal stromal cells and their phagocytic capacity
- Persistent Post COVID-19 Symptoms and Functional Status after 12-14 weeks of recovery, Tamil Nadu, India, 2021
- COVID-19 vaccination related exacerbations of hair loss in patients with moderate-to-severe alopecia areata on systemic therapy
- Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs
- The Chemical and Pharmacological Research Progress on a Kind of Chinese Herbal Medicine, Fructus Malvae
- Use of 5% Topical Minoxidil Application for Telogen Effluvium: An Open‐Label Single‐Arm Clinical Trial
- 51297 Low dose oral minoxidil in COVID-19-associated telogen effluvium. A retrospective analysis of 69 patients.